Tiverton Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $78K | Hold |
10,419
| – | – | ﹤0.01% | 663 |
|
|
2019
Q2 | $97K | Hold |
10,419
| – | – | ﹤0.01% | 626 |
|
|
2019
Q1 | $55K | Sell |
10,419
-2,244
| -18% | -$11.8K | ﹤0.01% | 628 |
|
|
2018
Q4 | $56K | Buy |
+12,663
| New | +$56K | ﹤0.01% | 438 |
|
|
2018
Q3 | – | Sell |
-132,318
| Closed | -$929K | – | 421 |
|
|
2018
Q2 | $929K | Hold |
132,318
| – | – | 0.05% | 197 |
|
|
2018
Q1 | $1.88M | Hold |
132,318
| – | – | 0.13% | 120 |
|
|
2017
Q4 | $1.16M | Sell |
132,318
-14,754
| -10% | -$129K | 0.07% | 174 |
|
|
2017
Q3 | $1.72M | Buy |
147,072
+9,340
| +7% | +$109K | 0.1% | 146 |
|
|
2017
Q2 | $1.92M | Buy |
137,732
+54,560
| +66% | +$762K | 0.1% | 150 |
|
|
2017
Q1 | $1.14M | Hold |
83,172
| – | – | 0.06% | 164 |
|
|
2016
Q4 | $596K | Sell |
83,172
-39,964
| -32% | -$286K | 0.04% | 180 |
|
|
2016
Q3 | $1.87M | Buy |
123,136
+114,524
| +1,330% | +$1.74M | 0.15% | 130 |
|
|
2016
Q2 | $760K | Sell |
8,612
-280,138
| -97% | -$24.7M | 0.03% | 148 |
|
|
2016
Q1 | $3.85M | Buy |
+288,750
| New | +$3.85M | 0.13% | 119 |
|